- Original article
- Open Access
Dynamic changes of mitral valve annulus geometry at preprocedural CT: relationship with functional classes of regurgitation
European Radiology Experimental volume 5, Article number: 34 (2021)
We investigated mitral valve annular geometry changes during the cardiac cycle in patients with severe mitral regurgitation (MR) who underwent cardiac computed tomography angiography (CCTA) prior to percutaneous mitral valve replacement or annuloplasty.
Fifty-one patients with severe MR and high surgical risk (Carpentier classification: 3 type I, 16 type II, 16 type IIIa, 16 type IIIb) underwent multiphase electrocardiographically gated (0–90%) CCTA, using a second generation dual-source CT scanner, as pre-procedural planning. Twenty-one patients without MR served as controls. The mitral valve annulus was segmented every 10% step of the R-R interval, according to the D-shaped segmentation model, and differences among groups were analysed by t-test or ANOVA.
Mitral annular area and diameters were larger in MR patients compared to controls, particularly in type II. Mitral annular area varied in MR patients throughout the cardiac cycle (mean ± standard deviation of maximum and minimum area 15.6 ± 3.9 cm2 versus 13.0 ± 3.5 cm2, respectively; p = 0.001), with greater difference between annular areas versus controls (2.59 ± 1.61 cm2 and 1.98 ± 0.6 cm2, p < 0.001). The largest dimension was found in systolic phases (20–40%) in most of MR patients (n = 27, 53%), independent of Carpentier type (I: n = 1, 33%; II: n = 10, 63%; IIIa: n = 8, 50%; IIIb: n = 8, 50%), and in protodiastolic phases (n = 14, 67%) for the control group.
In severe MR, mitral annular area varied significantly throughout the cardiac cycle, with a tendency towards larger dimensions in systole.
At multiphase cardiac computed tomography angiography (CCTA), mitral valve annulus area showed greater modifications throughout the cardiac cycle in patients with mitral regurgitation than in the control group.
Mitral valve prolapse was characterised by larger annulus dimensions and greater changes in mitral valve area over the cardiac cycle at CCTA in comparison to the other functional regurgitation types.
The maximum annular area was mainly recorded within 20–40% of the cardiac cycle at CCTA.
Mitral valve regurgitation (MR) is the second most frequent valvular dysfunction in Europe, after aortic stenosis [1, 2]. It is estimated that around 10% of population aged over 75 have moderate to severe MR . It can be caused by structural abnormality of one or more components of the mitral valve (primary MR), or by the distortion of the mitral valve apparatus caused by left ventricle (LV) and/or left atrium (LA) remodelling (secondary MR) . Severe MR is a major source of morbidity and mortality worldwide and a frequent cause of heart failure, being associated with unfavourable prognosis when remains untreated . Despite surgery is the treatment of choice for patients with severe MR, approximately 50% of patients are not eligible for surgery due to comorbidities [3, 6]. In the recent years, transcatheter mitral valve implantation (TMVI) is emerging as an effective alternative to surgery in high-risk surgical candidates . TMVI revolutionised the management of mitral valve repair/replacement percutaneously based on MR aetiology and patients’ anatomical and clinical characteristics [7, 8]. Among the available treatment options, mitral valve replacement and annuloplasty have been considered in case of unfavourable anatomy for transcatheter mitral valve edge-to-edge repair. In fact, the preprocedural verification of anatomical suitability is crucial for the feasibility of the procedure. Correct mitral annulus sizing has been shown to be a major determinant for the procedure outcome to avoid severe complications due to oversizing (e.g., left ventricle outflow tract obstruction, annular rupture) or undersizing (e.g., prosthesis instability, paravalvular leak, residual regurgitation) [9, 10]. Echocardiography is the first line investigation to assess MR severity and its aetiology and for preprocedural planning and intraprocedural guidance . In particular, transthoracic echocardiography (TTE) provides a quantitative assessment of MR severity, determines the different MR mechanism, and evaluates ventricular volume and function . However, it is operator-dependent and can be affected by limited spatial resolution; it may also result inconclusive in patients with inadequate acoustic window. Preprocedural two-dimensional and three-dimensional transesophageal echocardiography (TEE) are essential to assess anatomical detail of mitral valve remodelling . It can also be utilised in patients with inconclusive TTE or in case of inadequate acoustic window for a more accurate estimation of MR severity and mechanism .
Cardiac computed tomography angiography (CCTA) plays a complementary role to echocardiography for TMVI preprocedural planning , providing additional and more precise anatomical data . CCTA provides isotropic volumes with high spatial and temporal resolution allowing highly detailed anatomical information of mitral valve and of cardiac structures over the entire cardiac cycle, providing information about their dynamic changes [11, 12]. Therefore, CCTA is of pivotal importance for accurate and reliable device sizing, for characterisation of the landing zone and the surrounding structures (e.g., calcification, left ventricle outflow tract, coronary arteries, coronary sinus), and furthermore for the assessment of vascular access [12,13,14,15]. Based on these facts, CCTA is becoming increasingly important in TMVI planning [11, 14, 16, 17].
Considering the importance of correct annular sizing for final outcome, there are several studies investigating the three-dimensional mitral apparatus geometry and its variations during the cardiac cycle in healthy individuals and in pathological condition using echocardiography [18,19,20,21,22], with discordant results mainly due to limited sample size, heterogeneous methods (bidimensional, three-dimensional TTE, TEE), and patients’ features. Despite CCTA is more accurate and highly reproducible than echocardiography, only few studies are available on mitral valve geometry changes which are mainly focused on mitral valve prolapse [23,24,25,26,27,28]. These studies reported discordant results regarding the cardiac phases with larger annular dimension (systole versus diastole) and the dynamic changes throughout the cardiac cycle (increased versus reduced dynamic changes). A comparative CT study of mitral valve geometry changes over the cardiac cycle in patients with severe MR and in patients without MR may clarify the pathological alteration of valvular geometry and dynamics occurring in relation to different functional MR mechanism.
The aim of the present study is to evaluate the changes of mitral valve annular geometry throughout cardiac cycle in patients with severe MR with different aetiologies, who underwent pre-procedural CCTA prior to percutaneous mitral valve replacement or annuloplasty.
This retrospective single-centre study was approved by the Institutional Review Board, and informed consent was signed. From January 2017 to October 2020, seventy-two patients with severe symptomatic MR (age > 18 years), with high surgical risk, were candidates for percutaneous mitral valve replacement or annuloplasty according to the 2017 ESC/EACTS guidelines . They underwent a preprocedural ECG-gated cardiac CT with retrospective multiphase acquisition (0–90% of the cardiac cycle). Patients with previous mitral valve surgery (n = 12), previous aortic surgery (n = 6), and degraded image quality due to respiratory motion artefacts (n = 3) were excluded.
Twenty-one patients with severe aortic stenosis, without MR and any previous valve or cardiac surgery who underwent retrospective multiphase ECG-gated cardiac CT (0–90% phases of the cardiac cycle) for TAVR planning, were considered as the control group. Additional inclusion criteria for the control group were preserved EF, normal sinus rhythm, absent mitral valve calcification and/or the aorto-mitral curtain, and optimal image quality (without breathing artefact). Enrolment flowchart is reported in Fig. 1.
CCTA acquisition protocol
All cardiac scans were performed using a II generation dual-source scanner (Somatom Definition Flash, Siemens Healthineers, Erlangen, Germany) with a retrospective ECG-gated acquisition, using the automatic tube voltage and current selection systems (CARE kV and CARE Dose4D, Siemens Healthineers), with reference tube voltage of 120 kVp and reference tube current-time product of 350 mAs/rotation. Gantry rotation time was 0.28 s, and helical pitch was automatically selected according to patients’ heart rate. All cardiac CT scan were synchronised with the first pass of contrast agent using automatic bolus-tracking method. Iodinated contrast media (Visipaque 320, General Electric Healthcare, Chicago, IL, USA) was administered using triphasic injection scheme: 70 mL contrast agent, followed by 40 mL of mixed solution (25% contrast agent and 75% saline), followed by further 40 mL of pure saline (total volume 80 mL).
Patients with severe MR and depressed ejection fraction showed limited tolerance to negative chronotropic/inotropic agent. Therefore, low-dose beta-blocker or diltiazem could be considered only in patients with heart rate above 100 bpm . Since heart rate was under 100 bpm in all patients (72 ± 13 bpm in MR group and 68 ± 9 bpm in control group), no premedication for heart rate control was administered prior to CCTA acquisition .
Multiphase images were reconstructed in standard fashion at every 10% of the R-R interval (0–90%), at a slice thickness of 0.6 mm with an increment of 0.5 mm, using smooth kernel (I36) and an iterative reconstruction algorithm (SAFIRE, strength 2, Siemens Healthineers).
CCTA image analysis
Image analysis was performed independently by two radiologists with different level of experience in cardiovascular imaging (D.V. and A.P. with 3 and 10 years of experience, respectively) blinded to clinical data, using reformatted reconstructions of the annulus plane using a dedicated software (Philips Intellispace Portal v8.0, Amsterdam, The Netherlands).
According to the D-shaped segmentation model (Fig. 2), the mitral valve annulus area and diameters [trigone-to-trigone distance (TT), intercommissural diameter (IC), and septal-to-lateral diameter (SL)] were measured every 10% of the entire R-R interval [23, 31, 32], in order to assess their dynamic changes. Furthermore, automatic segmentation of cardiac chamber has been performed with the calculation of left ventricular ejection fraction (LV-EF), left ventricular end-diastolic volume (LV-EDV), and left atrial end-systolic volume (LA-ESV).
Preprocedural transesophageal echocardiographic (TOE) study was performed in all patients. Images were obtained with GE Vivid E9 or GE Vivid E95 (General Electric Healthcare, Chicago, IL) and post-processed with the EchoPAC® General Electric software by two physicians (L.P. and E.A.) in consensus. LV-EF, LV-EDV, and LA-ESV were measured following the ASE guidelines .
Carpentier classification of mitral valve regurgitation based on leaflet motion was performed [34,35,36], and patients were classified as type I (normal leaflet motion and position), type II (excessive leaflet motion), type IIIa (restricted leaflet motion in both systole and diastole), and type IIIb (restricted leaflet motion only in systole) (Fig. 3). In detail, type I includes patients with leaflet perforation or cleft and patients with atrial fibrillation or with non-ischemic cardiomyopathy; type II includes patients with mitral valve prolapse, due to Barlow’s disease or fibroelastic deficiency, or patients with cordal or papillary muscle elongation or rupture; type IIIa includes patients with leaflet thickening and/or retraction, cordal thickening and/or shortening, and commissural fusion like in cases of rheumatic mitral valve disease, mitral annular calcification, and drug-induced mitral valve disease; type IIIb includes patients with impairment of LV function with annulus dilatation and papillary muscle displacement for example in case of ischemic cardiomyopathy.
Continuous variables were expressed as mean ± standard deviation and categorical variables as percentage. Changes in the mitral annular dimensions throughout each phase of the cardiac cycle (0–90%) were analysed in each patient’s group and expressed as mean ± standard deviation.
Maximum and minimum mitral annulus area and annular dimensions between MR and control groups were compared using Student’s t test (normality was assessed by Kolmogorov-Smirnov test).
Differences in mitral annulus area and diameters among Carpentier’s classes and control group were evaluated using analysis of variance (ANOVA). Bonferroni tests were used as a post hoc analysis among the groups. Correlation analysis between mitral annulus area and clinical parameters (age, gender, BSA), and cardiac chamber volumes and function on CCTA was assessed using Pearson or Spearman correlation tests. To evaluate the agreement and reproducibility of the measurement between the two readers, the intraclass correlation coefficient (ICC) was used (ICC excellent 0.75–1.00; good 0.60–0.74; fair 0.40–0.59; and poor < 0.40) . Statistical analyses were performed using SPSS Statistics Version 20 (IBM, Armonk, NY); p-values < 0.05 were considered statistically significant.
Baseline characteristics of patients with MR and control subjects are reported in Table 1.
Patients with MR were mainly men (n = 27, 53%) with a mean age of 72 ± 14 years old. They were classified as follows: 3 patients (5.8%) with Carpentier type I, 16 patients (31.4%) with type II, 16 patients (31.4%) with type IIIa, and 16 patients (31.4%) with type IIIb. Most of the patients with MR (n=30, 59%) had atrial fibrillation. Control group included 21 subjects with mean age of 80 ± 6 years old, and among them, 43% (9/21) were male.
Mitral annulus geometry
Table 2 and Fig. 4 show the minimum and maximum annulus area, IC, SL, and TT diameters in MR and control groups as well as its changes throughout the cardiac cycle. Maximum area and diameters were significantly larger in MR patients in comparison to control subjects (p < 0.001) except for TT distance (p = 0.207, Table 2). The SL/IC ratio, index of ellipticity, was greater in MR than in control patients (0.82 ± 0.09 versus 0.73 ± 0.05; p < 0.001).
MR Carpentier types showed significantly different annular area (p = 0.002), IC (p = 0.002), and SL (p = 0.013) diameters (Table 3). Carpentier type II showed largest area (18.0 ± 4.5 cm2), IC diameter (52.6 ± 6.4 mm), and SL diameter (42.5 ± 6.4 mm), however, with only significant difference compared with Carpentier type IIIa (p = 0.001 for each parameters).
No differences were reported in TT diameter among each Carpentier types (p = 0.152).
The maximum annulus area in MR group was correlated to male sex (r = 0.402, p = 0.003), LV-EDV (r = 0.378, p = 0.006), and LA-ESV (r = 0.565, p < 0.001). It was not significantly correlated with age (r = −0.224, p = 0.114), BSA (r = 0.052, p = 0.765), LV-EF (r = 0.089, p = 0.536), and atrial fibrillation (r = 0.062, p = 0.670). In the control group, the annulus area was significantly correlated with BSA (r = 0.71, p = 0.001), male sex (r = 0.60, p = 0.005), LV-EDV (r = 0.73, p = 0.001), and LA-ESV (r = 0.52, p = 0.020) but not with LV-EF (r = 0.14, p = 0.547).
Mitral annulus dynamic changes in the cardiac cycle (0–90%)
Exemplifying cases of mitral valve annulus modification in the cardiac cycle in control subjects and Carpentier MR classes are reported in Fig. 5. The maximum and minimum value of the mitral annulus area across the entire cardiac cycle (0–90%) were significantly different in the MR group (15.6 ± 3.9 versus 13.0 ± 3.5 cm2 respectively, p = 0.001) as well as in the control group (9.62 ± 1.76 cm2 versus 7.60 ± 1.65 cm2 respectively, p < 0.001), with greater difference in MR patients compared to control subject (2.59 ± 1.61 versus 1.98 ± 0.6 cm2, p < 0.001). This result is driven mainly by Carpentier type II patients, which showed greater difference between maximum and minimum annulus areas (3.73 ± 2.25 cm2; p < 0.001) (Table 4 and Fig. 6).
Less dynamic changes were observed in types I, IIIa, and IIIb across the cardiac cycle (Fig. 6). In the MR group, the minimum valvular area was found mainly at 0–20% of cardiac cycle (23/51 patients, 45%) while the maximum area was mainly observed at 20–40% phases of cardiac cycle (n = 27, 53%) (Fig. 7). This was due to larger annulus area in systolic phase (20–40%) in type II, type IIIa, and type IIIb, while type I MR showed random distribution of the maximum area.
In the control group, the minimum and maximum areas were more homogeneously distributed, with minimum area mostly found in 0–20% phases of the cardiac cycle (n = 14, 67%) and the maximum area mainly in protodiastolic phases (40–60% of the cardiac cycle, n = 14, 67%) (Fig. 7).
The interobserver agreement was excellent for all the analysed parameters: annular area (ICC 0.94, 95% confidence interval (CI), 0.91–0.95), IC diameter (ICC 0.91, 95% CI, 0.89–0.93), SL diameter (ICC 0.91, 95% CI 0.86–0.94), and TT distance (ICC 0.87, 95% CI 0.78–0.96).
Correct mitral annulus measurement is of pivotal importance for device sizing and for a successful TMVI procedure [10, 15]. The understanding of the dynamic changes of the mitral annulus geometry across the cardiac cycle has implications on landing zone and device delivery .
Previous studies showed discordant results regarding mitral valve geometry changes in patients with MR [14, 16, 17, 28]. Therefore, an improvement in understanding of mitral valve geometry and dynamic changes across the cardiac cycle in relation to the different functional aetiologies of MR is of great importance to improve CCTA scanning protocol in order to improve image analysis and reduce radiation exposure.
To the best of our knowledge, this is the first study providing a multiphase CCTA characterisation of mitral annulus geometry in patients with severe MR of different functional aetiologies.
Main findings of the present study were mitral valve annulus was significantly enlarged in severe MR patients (p < 0.001), especially in mitral valve prolapse (Carpentier type II), which were also characterised by greater changes of mitral annulus area and diameters during the cardiac cycle (p = 0.002, p = 0.002, and p = 0.013 for mitral annulus area, IC, and SL diameters, respectively). Largest annular area was mainly observed in systolic phases (20–40% phases) in severe MR patients (53%), differently from control subjects with largest annular area mostly found in protodiastolic phases (40–60% phases, 67% of patients). Finally, the mitral annulus area changed significantly during the cardiac cycle, independently from the presence of MR, with the greatest change in Carpentier type II.
Our findings are in accordance with previous studies on echocardiography [20, 22, 39, 40] and CCTA [23,24,25] that demonstrated a significant mitral valve annulus enlargement in patients with mitral valve prolapse (Carpentier type II) and moderate-to-severe MR. This is probably related to both an increased outward tension during systole caused by excessive valve tissue and to mitral annular disjunction that causes the displacement of the posterior leaflet and annulus into the left atrium.
Some studies suggested a correlation between mitral valve area and left cardiac chamber volumes in the end-stage MR, independent of different leaflet motion alterations [20, 23, 25, 39, 40]; our results confirmed the aforementioned findings. Similarly to the control group, in MR patients, larger annular area was found in men [23, 25, 41, 42], while no significant correlation was achieved with BSA, which is likely due to the massive annular dilation and end-stage mitral valve apparatus remodelling in the patients with severe MR.
Larger mitral annulus area was found mostly in systolic phases in type II and types IIIa and IIIb MR patients, differently from control subjects in which larger dimension was mainly observed in early- to mid-diastolic phases (40–60%, n=14, 67% of cases). This finding is in accordance with a previous CCTA study . Larger systolic dimensions in MR patients is likely due to systolic annular overexpansion and/or disjunction in type II [18, 25, 43] and annulus enlargement with systolic contractility dysfunction in type III MR patients . Patients with mitral prolapse showed greater changes in mitral annulus area during the cardiac cycle, differently from other Carpentier types of MR, which were characterised by less dynamism. These findings were supported by previous CCTA studies on mitral valve prolapse  and functional MR [25, 32].
The low dynamic changes found in all Carpentier types except in type II might be more evident in our study compared to previous ones [25, 32], probably due to high prevalence of atrial fibrillation (30, 59%), which is likely to reduce the magnitude of dynamic changes of the mitral annulus during the cardiac cycle. Minimum annular dimension was found in the early systolic phase, caused by the active anteroposterior annulus contraction aimed to avoid early regurgitation [18, 20]. TT distance was not significantly enlarged in MR patients; this can be explained by the fact that the trigone zone and aorto-mitral curtain mainly consist of fibrotic tissue and thus being less prone to dilation, contrary to the posterior mitral annulus which is mainly muscular and consequently less resistant .
Mitral valve segmentation was performed using the D-shaped model, which is more accurate and reproducible than the saddle-shaped model in depicting the mitral annulus in MR patients [20, 24], and the planar landing zone of TMVI device [23, 31, 32]. In agreement with previous CCTA studies [20, 24], excellent accuracy of mitral annulus segmentation was found.
This study has some limitations: first, the relatively limited sample size. However, TMVI is a quite recent procedure for dedicated patients, therefore is performed in a limited and selected number of candidates. Only few patients with type I MR were included, reflecting the limited suitability of this category to these types of percutaneous treatment. Moreover, the control group consisted of patients without mitral valve disease who underwent multiphase CCTA for TAVR planning. Calcification of the aorto-mitral curtain determined a smaller mitral annulus area ; therefore, only patients with normal cardiac chamber volumes and function with no valvular calcification were included. Moreover, mitral annulus area and diameters in our control group were in line with previous data on healthy subjects , showing small valve area, delayed proto-diastolic peak, stable diastolic values, and a more efficient pre-systolic contraction with preserved contractility. A multiphase ECG-gated CCTA scan of the entire cardiac cycle cannot be justified in healthy subjects due to radiation exposure issue. Finally, our analysis is limited to the evaluation of only mitral valve annulus during the cardiac cycle. However, in the setting of TMVI, a number of additional parameters could be extracted from CCTA including calcification, leaflet tethering, abnormalities of papillary muscle insertion or anatomy, LVOT, regurgitant fraction, and percutaneous access .
In conclusion, our results showed largest annulus area mostly in systolic phases independently from the Carpentier MR type, with greater dynamic changes of the mitral annulus during the cardiac cycle in mitral valve prolapse compared to the other pathological conditions, which, on the contrary, were less dynamic.
Based on these findings, further research is required with aim of reducing radiation exposure. In fact, a multiphase ECG-gated CCTA acquisition with dose modulation should be considered. This would allow us to obtain full dose image acquisition in systole, necessary for better image definition and more accurate sizing, with reduced dose during the remaining phase of the cardiac cycle that could be however used to evaluate dynamic changes of cardiac structures, cardiac chamber volumes, and function.
Availability of data and materials
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Body surface area
Cardiac computed tomography angiography
Intraclass correlation coefficient
Left atrial end-systolic volume
Left ventricular end-diastolic volume
Left ventricular ejection fraction
Left ventricle outflow tract
Mitral valve regurgitation
Transcatheter mitral valve implantation
Iung B, Baron G, Butchart EG, et al (2003) A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J 24:1231–1243. https://doi.org/10.1016/S0195-668X(03)00201-X
Vahanian A, Alfieri O, Andreotti F et al (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33:2451–2496. https://doi.org/10.1093/eurheartj/ehs109
Markham R, Kyranis S, Aroney N, et al (2018) Transcatheter mitral valve intervention: an emerging treatment for mitral regurgitation. Intern Med J 48:382–390. https://doi.org/10.1111/imj.13750
Zoghbi WA, Adams D, Bonow RO, et al (2017) Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 30:303–371. https://doi.org/10.1016/j.echo.2017.01.007
Enriquez-Sarano M, Avierinos J-F, Messika-Zeitoun D, et al (2005) Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 352:875–883. https://doi.org/10.1056/nejmoa041451
Mirabel M, Iung B, Baron G, et al (2007) What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 28:1358–1365. https://doi.org/10.1093/eurheartj/ehm001
Vahanian A, Urena M, Ince H, Nickenig G (2017) Mitral valve: repair/clips/cinching/chordae. EuroIntervention 13:AA22–AA30. https://doi.org/10.4244/EIJ-D-17-00505
De Bonis M, Al-Attar N, Antunes M et al (2016) Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology working groups on cardiovascular surgery and valvular heart disease. Eur Heart J 37:133–139. https://doi.org/10.1093/eurheartj/ehv322
Wang DD, Eng MH, Greenbaum AB, et al (2018) Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR). Catheter Cardiovasc Interv 92:379–387. https://doi.org/10.1002/ccd.27447
Lee JZ, Tey KR, Mizyed A, Hennemeyer CT, Janardhanan R, Lotun K (2015) Mitral valve replacement complicated by iatrogenic left ventricular outflow obstruction and paravalvular leak: case report and review of literature. BMC Cardiovasc Disord 15:119. https://doi.org/10.1186/s12872-015-0108-z
Gheorghe LL, Mobasseri S, Agricola E, et al (2021) Imaging for native mitral valve surgical and transcatheter interventions. JACC Cardiovasc Imaging 14:112–127. https://doi.org/10.1016/j.jcmg.2020.11.021
Ranganath P, Moore A, Guerrero M, et al (2020) CT for pre-and postprocedural evaluation of transcatheter mitral valve replacement. Radiographics 40:1528–1553. https://doi.org/10.1148/rg.2020200027
Guerrero M, Wang DD, Pursnani A, et al (2020) A cardiac computed tomography–based score to categorize mitral annular calcification severity and predict valve embolization. JACC Cardiovasc Imaging 13:1945–1957. https://doi.org/10.1016/j.jcmg.2020.03.013
Faggioni L, Gabelloni M, Accogli S, et al (2018) Preprocedural planning of transcatheter mitral valve interventions by multidetector CT: what the radiologist needs to know. Eur J Radiol Open 5:131–140. https://doi.org/10.1016/j.ejro.2018.08.005
Blanke P, Naoum C, Dvir D, et al (2017) Predicting LVOT obstruction in transcatheter mitral valve implantation: concept of the Neo-LVOT. JACC Cardiovasc Imaging 10:482–485. https://doi.org/10.1016/j.jcmg.2016.01.005
Blanke P, Naoum C, Webb J, et al (2015) Multimodality imaging in the context of transcatheter mitral valve replacement establishing consensus among modalities and disciplines. JACC Cardiovasc Imaging 8:1191–1208. https://doi.org/10.1016/j.jcmg.2015.08.004
Grover R, Ohana M, Arepalli CD, et al (2018) Role of MDCT imaging in planning mitral valve intervention. Curr Cardiol Rep 20:16. https://doi.org/10.1007/s11886-018-0960-4
Van Wijngaarden SE, Kamperidis V, Regeer MV et al (2018) Three-dimensional assessment of mitral valve annulus dynamics and impact on quantification of mitral regurgitation. Eur Heart J Cardiovasc Imaging 19:176–184. https://doi.org/10.1093/ehjci/jex001
Pouch AM, Vergnat M, McGarvey JR et al (2014) Statistical assessment of normal mitral annular geometry using automated three-dimensional echocardiographic analysis. Ann Thorac Surg 97:71–77. https://doi.org/10.1016/j.athoracsur.2013.07.096
Noack T, Janietz M, Lurz P, et al (2019) Dynamic mitral valve geometry in patients with primary and secondary mitral regurgitation: implications for mitral valve repair†. Eur J Cardio-Thoracic Surg 56:983–992. https://doi.org/10.1093/ejcts/ezz096
Aruta P, Muraru D, Guta AC, et al (2018) Comparison of mitral annulus geometry between patients with ischemic and non-ischemic functional mitral regurgitation: implications for transcatheter mitral valve implantation. Cardiovasc Ultrasound 16:27. https://doi.org/10.1186/s12947-018-0145-8
Faletra FF, Leo LA, Paiocchi VL, et al (2019) Anatomy of mitral annulus insights from non-invasive imaging techniques. Eur Heart J Cardiovasc Imaging 20:843–857. https://doi.org/10.1093/ehjci/jez153
Naoum C, Leipsic J, Cheung A, et al (2016) Mitral annular dimensions and geometry in patients with functional mitral regurgitation and mitral valve prolapse implications for transcatheter mitral valve implantation. JACC Cardiovasc Imaging 9:269–280. https://doi.org/10.1016/j.jcmg.2015.08.022
Alkadhi H, Desbiolles L, Stolzmann P, et al (2009) Mitral annular shape, size, and motion in normals and in patients with cardiomyopathy: evaluation with computed tomography. Invest Radiol 44:218–225. https://doi.org/10.1097/RLI.0b013e3181994a73
Rizvi A, Marcus RP, Guo Y, et al (2020) Dynamic computed tomographic assessment of the mitral annulus in patients with and without mitral prolapse. J Cardiovasc Comput Tomogr 14:502–509. https://doi.org/10.1016/j.jcct.2020.02.005
Banks T, Razeghi O, Ntalas I, et al (2018) Automated quantification of mitral valve geometry on multi-slice computed tomography in patients with dilated cardiomyopathy – implications for transcatheter mitral valve replacement. J Cardiovasc Comput Tomogr 12:329–337. https://doi.org/10.1016/j.jcct.2018.04.003
Thériault-Lauzier P, Dorfmeister M, Mylotte D, et al (2016) Quantitative multi-slice computed tomography assessment of the mitral valvular complex for transcatheter mitral valve interventions part 2: geometrical measurements in patients with functional mitral regurgitation. EuroIntervention 12:e1021–e1030. https://doi.org/10.4244/EIJY15M11_10
Koo HJ, Yang DH, Oh SY, et al (2014) Demonstration of mitral valve prolapse with CT for planning of mitral valve repair. Radiographics 34:1537–1553. https://doi.org/10.1148/rg.346130146
Baumgartner H, Falk V, Bax JJ, et al (2017) 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2786. https://doi.org/10.1093/eurheartj/ehx391
Pulerwitz TC, Khalique OK, Leb J, et al (2020) Optimizing cardiac CT protocols for comprehensive acquisition prior to percutaneous MV and TV repair/replacement. JACC Cardiovasc Imaging 13:836–850. https://doi.org/10.1016/j.jcmg.2019.01.041
Blanke P, Dvir D, Cheung A, et al (2014) A simplified D-shaped model of the mitral annulus to facilitate CT-based sizing before transcatheter mitral valve implantation. J Cardiovasc Comput Tomogr 8:459–467. https://doi.org/10.1016/j.jcct.2014.09.009
Blanke P, Dvir D, Naoum C, et al (2015) Prediction of fluoroscopic angulation and coronary sinus location by CT in the context of transcatheter mitral valve implantation. J Cardiovasc Comput Tomogr 9:183–192. https://doi.org/10.1016/j.jcct.2015.02.007
Lang RM, Badano LP, Victor MA et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1–39.e14. https://doi.org/10.1016/j.echo.2014.10.003
Carpentier A, Adams D, Filsoufi F (2010) Carpentier’s Reconstructive Valve Surgery - 1st Edition. Elsevier
de Groot-de Laat LE, McGhie J, Ren B, Frowijn R, Oei FB, Geleijnse ML (2019) A modified echocardiographic classification of mitral valve regurgitation mechanism: the role of three-dimensional echocardiography. J Cardiovasc Imaging 27:187–199. https://doi.org/10.4250/jcvi.2019.27.e29
El Sabbagh A, Reddy YNV, Nishimura RA (2018) Mitral valve regurgitation in the contemporary era: insights into diagnosis, management, and future directions. JACC Cardiovasc Imaging 11:628–643. https://doi.org/10.1016/j.jcmg.2018.01.009
Cicchetti DV (1994) Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess 6:284–290. https://doi.org/10.1037/1040-35188.8.131.524
Nishimura RA, Vahanian A, Eleid MF, Mack MJ (2016) Mitral valve disease - current management and future challenges. Lancet 387:1324–1334. https://doi.org/10.1016/S0140-6736(16)00558-4
Bryhn M, Gåarding L (1986) The mitral valve mechanism with normal and prolapsed leaflets in the light of a dynamic model. Clin Cardiol 9:483–486. https://doi.org/10.1002/clc.4960091003
Lee APW, Jin CN, Fan Y, Wong RHL, Underwood MJ, Wan S (2017) Functional implication of mitral annular disjunction in mitral valve prolapse: a quantitative dynamic 3D echocardiographic study. JACC Cardiovasc Imaging 10:1424–1433. https://doi.org/10.1016/j.jcmg.2016.11.022
Sonne C, Sugeng L, Watanabe N, et al (2009) Age and body surface area dependency of mitral valve and papillary apparatus parameters: assessment by real-time three-dimensional echocardiography. Eur J Echocardiogr 10:287–294. https://doi.org/10.1093/ejechocard/jen237
Mihǎilǎ S, Muraru D, Piasentini E et al (2014) Quantitative analysis of mitral annular geometry and function in healthy volunteers using transthoracic three-dimensional echocardiography. J Am Soc Echocardiogr 27:846–857. https://doi.org/10.1016/j.echo.2014.04.017
Enriquez-Sarano M (2017) Mitral annular disjunction: the forgotten component of myxomatous mitral valve disease. JACC Cardiovasc Imaging 10:1434–1436. https://doi.org/10.1016/j.jcmg.2017.03.001
Tsang W, Meineri M, Hahn RT, et al (2013) A three-dimensional echocardiographic study on aortic-mitral coupling in transcatheter aortic valve replacement. Eur Heart J Cardiovasc Imaging 14:950–956. https://doi.org/10.1093/ehjci/jet058
Weir-McCall JR, Blanke P, Naoum C et al (2018) Mitral valve imaging with CT: relationship with transcatheter mitral valve interventions. Radiology 288:638–655. https://doi.org/10.1148/radiol.2018172758
We would like to thank the OSR cardiovascular CT team for support.
Ethics approval and consent to participate
This retrospective study was approved by the Institutional Review Board of San Raffaele Scientific Institute, Milan on March 3rd 2020 ("Intra-procedural clip 2020" 28/INT/2020).
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Palmisano, A., Nicoletti, V., Colantoni, C. et al. Dynamic changes of mitral valve annulus geometry at preprocedural CT: relationship with functional classes of regurgitation. Eur Radiol Exp 5, 34 (2021). https://doi.org/10.1186/s41747-021-00231-3
- Computed tomography angiography
- Heart valve prosthesis
- Mitral valve
- Mitral valve insufficiency
- Planning techniques